Vycor Medical Inc. (VYCO) intrinsic value & 10-year financials
Vycor Medical Inc. (VYCO) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 2.8% a year to $1.9M, with an average return on invested capital of 144.7%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.07
- Market cap
- $2.2M
- Revenue (FY2025)
- $1.9M
- Revenue growth (10-yr CAGR)
- 2.8%
- ROIC (10-yr avg)
- 144.7%
- Free cash flow (FY2025)
- -$18.7K
VYCO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.9M | -$72.4K | -$0.01 | -$18.7K | 1.8% | 1.9% |
| FY2024 | $1.6M | -$107.2K | -$0.01 | $55.9K | -0.6% | 3.1% |
| FY2023 | $1.5M | -$69.7K | -$0.01 | $20.0K | 2.8% | 2.1% |
| FY2022 | $1.2M | -$404.9K | -$0.02 | -$219.8K | -25.1% | 17.6% |
| FY2021 | $1.4M | -$435.7K | — | -$17.0K | -31.3% | 21.2% |
| FY2020 | $1.1M | -$822.5K | — | -$310.8K | -63.7% | 45.7% |
| FY2019 | $1.5M | -$796.2K | — | -$51.0K | -48.9% | 75.0% |
| FY2018 | $1.5M | -$1.4M | — | -$323.8K | -87.3% | 401.3% |
| FY2017 | $1.4M | -$1.5M | — | -$710.7K | -94.8% | -5370.7% |
| FY2016 | $1.5M | -$1.7M | — | -$554.4K | -109.5% | 6249.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
VYCOR MEDICAL INC has demonstrated mature, steady growth, with revenue compounding at 2.8% annually over the past decade.
VYCOR MEDICAL INC has earned high returns on invested capital, averaging 17.9% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
VYCOR MEDICAL INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, VYCOR MEDICAL INC is modeled at 2.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.12 per share.